Clinical Trial Update: Specified Drug-use Survey of the Granular Capsule Formulation of Omega-3 Fatty Acid Ethyl Esters: OCEAN3

View source ↗

Summary

A completed clinical trial update for the granular capsule omega-3 fatty acid ethyl esters (OCEAN3) surveying specified drug use in hyperlipidemia; results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia

Drugs mentioned

• omega-3 fatty acid ethyl esters (granular capsule formulation)

Snippet

Sponsor: Takeda | Conditions: Hyperlipidemia | Status: COMPLETED | Results posted: 2022-02-18